Neurogene Inc. · NASDAQ:NGNE
Great Point Partners LLC's stake in Neurogene Inc. fell to 2.98% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Great Point Partners LLC's stake in Neurogene Inc. fell to 2.98%, 442,761 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 2.98%
- Shares
- 442,761
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 2.98% | 442,761 |
| Dr. Jeffrey R. Jay, M.D. | 2.98% | 442,761 |
| Ms. Lillian Nordahl | 2.98% | 442,761 |
Source
Related
- Neurogene Inc.
- Great Point Partners LLC
- Neurogene Inc. shareholders
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026